Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression
- PMID: 8666924
- PMCID: PMC2192524
- DOI: 10.1084/jem.183.4.1663
Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression
Abstract
The hyaluronan (HA) receptor RHAMM is an important regulator of cell growth. Overexpression of RHAMM is transforming and is required for H-ras transformation. The molecular mechanism underlying growth control by RHAMM and other extracellular matrix receptors remains largely unknown. We report that soluble RHAMM induces G2/M arrest by suppressing the expression of Cdc2/Cyclin B1, a protein kinase complex essential for mitosis. Down-regulation of RHAMM by use of dominant negative mutants or antisense of mRNA also decreases Cdc2 protein levels. Suppression of Cdc2 occurs as a result of an increased rate of cdc2 mRNA degradation. Moreover, tumor cells treated with soluble RHAMM are unable to form lung metastases. Thus, we show that mitosis is directly linked to RHAMM through control of Cdc2 and Cyclin B1 expression. Failure to sustain levels of Cdc2 and Cyclin B1 proteins leads to cell cycle arrest.
Similar articles
-
Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.Int J Oncol. 2009 Oct;35(4):761-73. doi: 10.3892/ijo_00000389. Int J Oncol. 2009. PMID: 19724912
-
Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation.FEBS Lett. 2005 Aug 29;579(21):4757-62. doi: 10.1016/j.febslet.2005.07.053. FEBS Lett. 2005. PMID: 16102754 Free PMC article.
-
Nuclear localization of cyclin B1 controls mitotic entry after DNA damage.J Cell Biol. 1998 May 18;141(4):875-85. doi: 10.1083/jcb.141.4.875. J Cell Biol. 1998. PMID: 9585407 Free PMC article.
-
Regulation of the G2/M transition by p53.Oncogene. 2001 Apr 5;20(15):1803-15. doi: 10.1038/sj.onc.1204252. Oncogene. 2001. PMID: 11313928 Review.
-
Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis.J Neurooncol. 1995 Dec;26(3):221-9. doi: 10.1007/BF01052625. J Neurooncol. 1995. PMID: 8750188 Review.
Cited by
-
Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.BMC Genomics. 2006 Nov 16;7:292. doi: 10.1186/1471-2164-7-292. BMC Genomics. 2006. PMID: 17109758 Free PMC article.
-
Hyaluronan Receptors as Mediators and Modulators of the Tumor Microenvironment.Adv Healthc Mater. 2023 Feb;12(5):e2202118. doi: 10.1002/adhm.202202118. Epub 2022 Nov 28. Adv Healthc Mater. 2023. PMID: 36373221 Free PMC article. Review.
-
Hyaluronan, Inflammation, and Breast Cancer Progression.Front Immunol. 2015 Jun 8;6:236. doi: 10.3389/fimmu.2015.00236. eCollection 2015. Front Immunol. 2015. PMID: 26106384 Free PMC article. Review.
-
Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair.J Cell Biol. 2006 Dec 18;175(6):1017-28. doi: 10.1083/jcb.200511027. Epub 2006 Dec 11. J Cell Biol. 2006. PMID: 17158951 Free PMC article.
-
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.J Biol Chem. 2007 Jun 1;282(22):16667-80. doi: 10.1074/jbc.M702078200. Epub 2007 Mar 28. J Biol Chem. 2007. PMID: 17392272 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous